Mark Erlander | executive |
James Levine | executive |
Fairooz Kabbinavar | executive |
Marc Frahm | analyst |
Joseph Catanzaro | analyst |
Tsan-Yu Hsieh | analyst |
Welcome to the Cardiff Oncology Fourth Quarter and Full Year 2023 Financial Results and Corporate Update Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded.
I would now like to turn the conference over to Laurence Watts, Gilmartin Group. Please go ahead.
Thank you, operator.